Post by
runningonempty on Jan 20, 2016 3:55pm
No one really knows the outcome.
Lots of comments and concern here going forward with approval from FDA. No one is sure what the outcome will be especially with failed ADCOM. (no getting around that)
TST needs to pull out all stops and convince FDA to approve MCNA in some way. Hopefully they have been working behind the scene to get the job done. So its going to be a nail biter right up until the end. I am hoping they can pull it off, but still wary they can.
Even though lots of doom, Euro Pacific has come out with a speculative buy and a 1.25 target price based on limited approval. They recognize ADCOM failure, but still expect an approval from FDA. I believe TST has been manufacturing and stockpiling MCNA ready to bring to market if approved. This is beneficial for concerns with BCG shortage and instant sales going forward. IPSEN has not nixed deal they signed with TST in wake of ADCOM, so they believe approval can happen, same for the private placement as they are still on board with TST.
So lots to be positive going forward, only one major hurdle in front of us, FDA.
Comment by
PharmaGuy42 on Jan 20, 2016 7:19pm
I would say this is an accurate representation of the way things are. No one reall knows the outcome, but it`s not doom and gloom. It`s a rare situation with so many points to consider and a very strong case can be built for the outcome going either way.